Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol
HIT Consultant
NOVEMBER 30, 2022
a power Visa and ultimately the government could not deny. A similar inflection point now faces the specialty pharmaceutical industry. Yet for specialty pharmaceutical patients, interacting with stakeholders in multiple silos is the norm. You may ask: Can an open protocol be HIPAA compliant? Visa’s attempted $5.3
Let's personalize your content